4//SEC Filing
Muller Lorenz 4
Accession 0001415889-25-019771
CIK 0001408443other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:15 PM ET
Size
9.4 KB
Accession
0001415889-25-019771
Insider Transaction Report
Form 4
Muller Lorenz
Chief Commercial Officer
Transactions
- Award
Series A Common Warrants (right to buy)
2025-07-11+66,666→ 66,666 totalExercise: $1.50Exp: 2026-07-11→ Common Shares (66,666 underlying) - Award
Series B Common Warrants (right to buy)
2025-07-11+66,666→ 66,666 totalExercise: $1.88Exp: 2030-07-11→ Common Shares (66,666 underlying) - Award
Common Shares
2025-07-11+66,666→ 175,052 total
Footnotes (2)
- [F1]The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock.
- [F2]Fully vested and exercisable.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
Related Parties
1- filerCIK 0001771207
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 4:15 PM ET
- Size
- 9.4 KB